NanoVibronix Statistics
Total Valuation
NanoVibronix has a market cap or net worth of $2.70 million. The enterprise value is $1.52 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NanoVibronix has 715,728 shares outstanding. The number of shares has increased by 55.07% in one year.
| Current Share Class | 715,728 |
| Shares Outstanding | 715,728 |
| Shares Change (YoY) | +55.07% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 1.01% |
| Owned by Institutions (%) | 2.21% |
| Float | 708,194 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| Forward PS | n/a |
| PB Ratio | 0.51 |
| P/TBV Ratio | 1.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.07.
| Current Ratio | 1.74 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -23.22 |
Financial Efficiency
Return on equity (ROE) is -94.09% and return on invested capital (ROIC) is -47.60%.
| Return on Equity (ROE) | -94.09% |
| Return on Assets (ROA) | -26.51% |
| Return on Invested Capital (ROIC) | -47.60% |
| Return on Capital Employed (ROCE) | -118.19% |
| Revenue Per Employee | $205,688 |
| Profits Per Employee | -$192,938 |
| Employee Count | 16 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 0.49 |
Taxes
In the past 12 months, NanoVibronix has paid $25,000 in taxes.
| Income Tax | 25,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.23% in the last 52 weeks. The beta is 1.81, so NanoVibronix's price volatility has been higher than the market average.
| Beta (5Y) | 1.81 |
| 52-Week Price Change | -63.23% |
| 50-Day Moving Average | 4.32 |
| 200-Day Moving Average | 6.39 |
| Relative Strength Index (RSI) | 47.99 |
| Average Volume (20 Days) | 2,269,031 |
Short Selling Information
The latest short interest is 38,693, so 5.41% of the outstanding shares have been sold short.
| Short Interest | 38,693 |
| Short Previous Month | 267,582 |
| Short % of Shares Out | 5.41% |
| Short % of Float | 5.46% |
| Short Ratio (days to cover) | 0.29 |
Income Statement
In the last 12 months, NanoVibronix had revenue of $3.29 million and -$3.09 million in losses. Loss per share was -$13.44.
| Revenue | 3.29M |
| Gross Profit | 1.96M |
| Operating Income | -2.55M |
| Pretax Income | -3.17M |
| Net Income | -3.09M |
| EBITDA | -2.55M |
| EBIT | -2.55M |
| Loss Per Share | -$13.44 |
Full Income StatementBalance Sheet
The company has $1.31 million in cash and $126,000 in debt, giving a net cash position of $1.18 million or $1.65 per share.
| Cash & Cash Equivalents | 1.31M |
| Total Debt | 126,000 |
| Net Cash | 1.18M |
| Net Cash Per Share | $1.65 |
| Equity (Book Value) | 1.87M |
| Book Value Per Share | 7.40 |
| Working Capital | 1.86M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.46 million and capital expenditures -$3,000, giving a free cash flow of -$2.46 million.
| Operating Cash Flow | -2.46M |
| Capital Expenditures | -3,000 |
| Free Cash Flow | -2.46M |
| FCF Per Share | -$3.44 |
Full Cash Flow StatementMargins
Gross margin is 59.62%, with operating and profit margins of -77.61% and -93.80%.
| Gross Margin | 59.62% |
| Operating Margin | -77.61% |
| Pretax Margin | -93.04% |
| Profit Margin | -93.80% |
| EBITDA Margin | -77.58% |
| EBIT Margin | -77.61% |
| FCF Margin | n/a |